发明名称 |
Methods and compositions for increasing alpha-iduronidase activity in the CNS |
摘要 |
Provided herein are methods and compositions for treating a subject suffering from a deficiency in a-L-Iduronidase in the CNS. The methods include systemic administration of a bifunctional fusion antibody comprising an antibody to a human insulin receptor and an a-L-Iduronidase. A therapeutically effective systemic dose is based on the specific CNS uptake characteristics of human insulin receptor antibody-a-L-Iduronidase fusion antibodies as described herein. -48 4478550_1 (GHMatters) P83171.AU.1 |
申请公布号 |
AU2013206657(A1) |
申请公布日期 |
2013.07.18 |
申请号 |
AU20130206657 |
申请日期 |
2013.07.03 |
申请人 |
ARMAGEN TECHNOLOGIES, INC. |
发明人 |
PARDRIDGE, WILLIAM M.;BOADO, RUBEN J. |
分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|